Chi Meng

875 total citations
41 papers, 661 citations indexed

About

Chi Meng is a scholar working on Molecular Biology, Biomedical Engineering and Pharmacology. According to data from OpenAlex, Chi Meng has authored 41 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Biomedical Engineering and 6 papers in Pharmacology. Recurrent topics in Chi Meng's work include Nanoplatforms for cancer theranostics (11 papers), Histone Deacetylase Inhibitors Research (6 papers) and Piperaceae Chemical and Biological Studies (6 papers). Chi Meng is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Histone Deacetylase Inhibitors Research (6 papers) and Piperaceae Chemical and Biological Studies (6 papers). Chi Meng collaborates with scholars based in China, Macao and United States. Chi Meng's co-authors include Yong Ling, Jianqiang Qian, Zhongyuan Xu, Peng Zhu, Chang‐Chun Ling, Guonian Wang, Jinlei Peng, Fude Feng, Yanan Zhang and Weizhong Zhu and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Colloid and Interface Science and Journal of Medicinal Chemistry.

In The Last Decade

Chi Meng

39 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi Meng China 16 255 161 158 92 85 41 661
Zhongyuan Xu China 17 253 1.0× 109 0.7× 128 0.8× 45 0.5× 72 0.8× 59 686
Yunzhan Li China 13 273 1.1× 154 1.0× 42 0.3× 101 1.1× 68 0.8× 18 710
Xiaocen Li China 14 507 2.0× 139 0.9× 107 0.7× 55 0.6× 44 0.5× 38 853
Filipa S. Carvalho Portugal 12 431 1.7× 136 0.8× 66 0.4× 81 0.9× 72 0.8× 18 1.1k
Song Wu China 18 308 1.2× 87 0.5× 80 0.5× 131 1.4× 48 0.6× 36 692
Sitanshu S. Singh United States 13 290 1.1× 127 0.8× 65 0.4× 49 0.5× 66 0.8× 26 585
Yuyan Li China 18 294 1.2× 56 0.3× 122 0.8× 107 1.2× 57 0.7× 51 1.0k
Judit Molnár Hungary 18 506 2.0× 138 0.9× 122 0.8× 54 0.6× 195 2.3× 40 1.1k
Markus Laube Germany 17 177 0.7× 89 0.6× 163 1.0× 44 0.5× 51 0.6× 65 729
Lakshminarayana Narayana India 9 112 0.4× 131 0.8× 121 0.8× 56 0.6× 66 0.8× 13 394

Countries citing papers authored by Chi Meng

Since Specialization
Citations

This map shows the geographic impact of Chi Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Meng more than expected).

Fields of papers citing papers by Chi Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Meng. The network helps show where Chi Meng may publish in the future.

Co-authorship network of co-authors of Chi Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Meng. A scholar is included among the top collaborators of Chi Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Meng. Chi Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Zhongyuan, Jianqiang Qian, Hongmei Wu, et al.. (2023). Novel pH-activatable NIR fluorogenic spray mediated near-instant and precise tumor margins identification in human cancer tissues for surgical resection. Theranostics. 13(13). 4497–4511. 5 indexed citations
3.
Meng, Chi, Ying Li, Duo Wang, et al.. (2023). Novel structured ADAM17 small-molecule inhibitor represses ADAM17/Notch pathway activation and the NSCLC cells’ resistance to anti-tumour drugs. Frontiers in Pharmacology. 14. 1189245–1189245. 4 indexed citations
4.
Wang, Yan, Mingming Li, Jing Gu, et al.. (2023). Prediction of immune and targeted drug efficacy in pain-related risk subtypes for bladder cancer patients. Heliyon. 9(7). e17690–e17690. 1 indexed citations
5.
Qian, Jianqiang, Zhongyuan Xu, Chi Meng, et al.. (2022). Redox-Activatable Theranostic Co-Prodrug for Precise Tumor Diagnosis and Selective Combination Chemotherapy. Journal of Medicinal Chemistry. 65(15). 10393–10407. 11 indexed citations
6.
Liu, Yun, Zhongyuan Xu, Chi Meng, et al.. (2022). Recent development of BTK-based dual inhibitors in the treatment of cancers. European Journal of Medicinal Chemistry. 233. 114232–114232. 23 indexed citations
7.
Meng, Chi, et al.. (2022). A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer. Computers in Biology and Medicine. 153. 106432–106432. 23 indexed citations
8.
Xu, Zhongyuan, Jianqiang Qian, Chi Meng, et al.. (2022). TME-targeting theranostic agent uses NIR tracking for tumor diagnosis and surgical resection and acts as chemotherapeutic showing enhanced efficiency and minimal toxicity. Theranostics. 12(6). 2535–2548. 12 indexed citations
9.
Liu, Xin, Chi Meng, Ji Liu, et al.. (2021). Tumor microenvironment-activatable boolean logic supramolecular nanotheranostics based on a pillar[6]arene for tumor hypoxia imaging and multimodal synergistic therapy. Materials Chemistry Frontiers. 5(15). 5846–5856. 10 indexed citations
10.
Qian, Jianqiang, Zhongyuan Xu, Peng Zhu, et al.. (2021). A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma. Journal of Natural Products. 84(12). 3161–3168. 17 indexed citations
11.
Liu, Xin, Ji Liu, Chi Meng, et al.. (2021). Pillar[6]arene-Based Supramolecular Nanocatalysts for Synergistically Enhanced Chemodynamic Therapy by the Intracellular Cascade Reaction. ACS Applied Materials & Interfaces. 13(45). 53574–53585. 24 indexed citations
12.
Zhu, Peng, Jianqiang Qian, Zhongyuan Xu, et al.. (2020). Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling. Journal of Natural Products. 83(10). 3041–3049. 31 indexed citations
13.
Liu, Ji, Xin Liu, Jianqiang Qian, et al.. (2020). Development of pH/Glutathione-Responsive Theranostic Agents Activated by Glutathione S-Transferase π for Human Colon Cancer. Journal of Medicinal Chemistry. 63(17). 9271–9283. 25 indexed citations
14.
Ling, Yong, Jianqiang Qian, Chi Meng, et al.. (2020). Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy. Current Medicinal Chemistry. 27(42). 7264–7288. 34 indexed citations
15.
Wang, Xiaomei, Jianqiang Qian, Peng Zhu, et al.. (2020). Novel Phenylmethylenecyclohexenone Derivatives as Potent TrxR Inhibitors Display High Antiproliferative Activity and Induce ROS, Apoptosis, and DNA Damage. ChemMedChem. 16(4). 702–712. 13 indexed citations
16.
Meng, Chi, et al.. (2020). Dexmedetomidine promotes breast cancer cell migration through Rab11-mediated secretion of exosomal TMPRSS2. Annals of Translational Medicine. 8(8). 531–531. 34 indexed citations
17.
Dai, Hong, Meiling Huang, Jianqiang Qian, et al.. (2019). Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids. European Journal of Medicinal Chemistry. 166. 470–479. 51 indexed citations
18.
Ling, Yong, Weijie Gao, Chang‐Chun Ling, et al.. (2019). β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma. European Journal of Medicinal Chemistry. 168. 515–526. 39 indexed citations
19.
Ling, Yong, Yangyang Li, Rui Zhu, et al.. (2019). Hydroxamic Acid Derivatives of β-Carboline/Hydroxycinnamic Acid Hybrids Inducing Apoptosis and Autophagy through the PI3K/Akt/mTOR Pathways. Journal of Natural Products. 82(6). 1442–1450. 36 indexed citations
20.
Zhang, Mingyue, et al.. (2017). Effects of coadministration of low dose cannabinoid type 2 receptor agonist and morphine on vanilloid receptor 1 expression in a rat model of cancer pain. Molecular Medicine Reports. 16(5). 7025–7031. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhongyuan Xu Breakdown of academic impact, for papers by Yunzhan Li Breakdown of academic impact, for papers by Xiaocen Li Breakdown of academic impact, for papers by Filipa S. Carvalho Breakdown of academic impact, for papers by Song Wu Breakdown of academic impact, for papers by Sitanshu S. Singh Breakdown of academic impact, for papers by Yuyan Li Breakdown of academic impact, for papers by Judit Molnár Breakdown of academic impact, for papers by Markus Laube Breakdown of academic impact, for papers by Lakshminarayana Narayana
Rankless by CCL
2026